Literature DB >> 8037208

Molecular basis of maple syrup urine disease: novel mutations at the E1 alpha locus that impair E1(alpha 2 beta 2) assembly or decrease steady-state E1 alpha mRNA levels of branched-chain alpha-keto acid dehydrogenase complex.

J L Chuang1, C R Fisher, R P Cox, D T Chuang.   

Abstract

We report the occurrence of three novel mutations in the E1 alpha (BCKDHA) locus of the branched-chain alpha-keto acid dehydrogenase (BCKAD) complex that cause maple syrup urine disease (MSUD). An 8-bp deletion in exon 7 is present in one allele of a compound-heterozygous patient (GM-649). A single C nucleotide insertion in exon 2 occurs in one allele of an intermediate-MSUD patient (Lo). The second allele of patient Lo carries an A-to-G transition in exon 9 of the E1 alpha gene. This missense mutation changes Tyr-368 to Cys (Y368C) in the E1 alpha subunit. Both the 8-bp deletion and the single C insertion generate a downstream nonsense codon. Both mutations appear to be associated with a low abundance of the mutant E1 alpha mRNA, as determined by allele-specific oligonucleotide probing. Transfection studies strongly suggest that the Y368C substitution in the E1 alpha subunit impairs its proper assembly with the normal E1 beta. Unassembled as well as misassembled E1 alpha and E1 beta subunits are degraded in the cell.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8037208      PMCID: PMC1918348     

Source DB:  PubMed          Journal:  Am J Hum Genet        ISSN: 0002-9297            Impact factor:   11.025


  27 in total

Review 1.  The 2-oxo acid dehydrogenase complexes: recent advances.

Authors:  S J Yeaman
Journal:  Biochem J       Date:  1989-02-01       Impact factor: 3.857

2.  Molecular phenotypes in cultured maple syrup urine disease cells. Complete E1 alpha cDNA sequence and mRNA and subunit contents of the human branched chain alpha-keto acid dehydrogenase complex.

Authors:  C W Fisher; J L Chuang; T A Griffin; K S Lau; R P Cox; D T Chuang
Journal:  J Biol Chem       Date:  1989-02-25       Impact factor: 5.157

3.  Molecular genetic heterogeneity of myophosphorylase deficiency (McArdle's disease).

Authors:  S Tsujino; S Shanske; S DiMauro
Journal:  N Engl J Med       Date:  1993-07-22       Impact factor: 91.245

4.  Evidence that the mitochondrial activator of phosphorylated branched-chain 2-oxoacid dehydrogenase complex is the dissociated E1 component of the complex.

Authors:  S J Yeaman; K G Cook; R W Boyd; R Lawson
Journal:  FEBS Lett       Date:  1984-06-25       Impact factor: 4.124

5.  Supercoil sequencing: a fast and simple method for sequencing plasmid DNA.

Authors:  E Y Chen; P H Seeburg
Journal:  DNA       Date:  1985-04

6.  Activation of phosphorylated branched chain 2-oxoacid dehydrogenase complex.

Authors:  H R Fatania; K S Lau; P J Randle
Journal:  FEBS Lett       Date:  1982-10-04       Impact factor: 4.124

7.  Nonsense mutations in the human beta-globin gene affect mRNA metabolism.

Authors:  S J Baserga; E J Benz
Journal:  Proc Natl Acad Sci U S A       Date:  1988-04       Impact factor: 11.205

8.  A distinct variant of intermediate maple syrup urine disease.

Authors:  M C Gonzalez-Rios; D T Chuang; R P Cox; K Schmidt; K Knopf; S Packman
Journal:  Clin Genet       Date:  1985-02       Impact factor: 4.438

9.  Premature translation termination mediates triosephosphate isomerase mRNA degradation.

Authors:  I O Daar; L E Maquat
Journal:  Mol Cell Biol       Date:  1988-02       Impact factor: 4.272

10.  Isolation of biologically active ribonucleic acid from sources enriched in ribonuclease.

Authors:  J M Chirgwin; A E Przybyla; R J MacDonald; W J Rutter
Journal:  Biochemistry       Date:  1979-11-27       Impact factor: 3.162

View more
  7 in total

1.  Phenylbutyrate therapy for maple syrup urine disease.

Authors:  Nicola Brunetti-Pierri; Brendan Lanpher; Ayelet Erez; Elitsa A Ananieva; Mohammad Islam; Juan C Marini; Qin Sun; Chunli Yu; Madhuri Hegde; Jun Li; R Max Wynn; David T Chuang; Susan Hutson; Brendan Lee
Journal:  Hum Mol Genet       Date:  2010-11-23       Impact factor: 6.150

2.  Maple syrup urine disease: the E1beta gene of human branched-chain alpha-ketoacid dehydrogenase complex has 11 rather than 10 exons, and the 3' UTR in one of the two E1beta mRNAs arises from intronic sequences.

Authors:  J L Chuang; R P Cox; D T Chuang
Journal:  Am J Hum Genet       Date:  1996-06       Impact factor: 11.025

3.  E2 transacylase-deficient (type II) maple syrup urine disease. Aberrant splicing of E2 mRNA caused by internal intronic deletions and association with thiamine-responsive phenotype.

Authors:  J L Chuang; R P Cox; D T Chuang
Journal:  J Clin Invest       Date:  1997-08-01       Impact factor: 14.808

4.  Maple syrup urine disease (MSUD): screening for known mutations in Italian patients.

Authors:  T Parrella; S Surrey; A Iolascon; M Sartore; R Heidenreich; G Diamond; A Ponzone; O Guardamagna; A B Burlina; R Cerone
Journal:  J Inherit Metab Dis       Date:  1994       Impact factor: 4.982

5.  Maple syrup urine disease in Cypriot families: identification of three novel mutations and biochemical characterization of the p.Thr211Met mutation in the E1alpha subunit.

Authors:  Theodoros Georgiou; Jacinta L Chuang; R Max Wynn; Goula Stylianidou; Mark Korson; David T Chuang; Anthi Drousiotou
Journal:  Genet Test Mol Biomarkers       Date:  2009-10

6.  Molecular and biochemical basis of intermediate maple syrup urine disease. Occurrence of homozygous G245R and F364C mutations at the E1 alpha locus of Hispanic-Mexican patients.

Authors:  J L Chuang; J R Davie; J M Chinsky; R M Wynn; R P Cox; D T Chuang
Journal:  J Clin Invest       Date:  1995-03       Impact factor: 14.808

7.  Promising Metabolite Profiles in the Plasma and CSF of Early Clinical Parkinson's Disease.

Authors:  Daniel Stoessel; Claudia Schulte; Marcia C Teixeira Dos Santos; Dieter Scheller; Irene Rebollo-Mesa; Christian Deuschle; Dirk Walther; Nicolas Schauer; Daniela Berg; Andre Nogueira da Costa; Walter Maetzler
Journal:  Front Aging Neurosci       Date:  2018-03-05       Impact factor: 5.750

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.